Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Mark

Showing results (111-120 of 2,047) with videos related to

Pageof 205
Sort By:
Clinical Advances in Hematology & Oncology : H&O|April 9, 2016
The impact of value-based insurance design on oncology drugsA Mark Fendrick
Circulation. Heart Failure|March 15, 2017
Circulating Biomarkers of Cardiac Fibrosis: Do We Have Any and What Use Are They?A Mark Richards
Journal of Sports Sciences|March 18, 2017
Journal of Sports Sciences: past, present and futureA Mark Williams
The American Journal of Managed Care|November 25, 2003
Mechanisms to improve pharmaceutical use in managed care: to study controls, control the studiesA Mark Fendrick
Journal of Child Health Care : for Professionals Working with Children in the Hospital and Community|April 20, 2004
ADHD and drug therapy: is it still a valid treatment?A Mark Doggett
Age and Ageing|November 4, 2005
Reversible dementia--the implications of a fall in prevalenceA Mark Clarfield
Canadian Family Physician Medecin De Famille Canadien|September 17, 2002
Treating family members: call your doctor in the morningA Mark Clarfield
The American Journal of Managed Care|December 3, 2002
Cost-effective use of NSAIDs: issues pertinent to coxib use in managed careA Mark Fendrick
Cleveland Clinic Journal of Medicine|June 28, 2002
Developing an economic rationale for the use of selective COX-2 inhibitors for patients at risk for NSAID gastropathyA Mark Fendrick
Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie|January 7, 2003
Protection from aspiration with the LMA-ProSeal after vomiting: a case reportDavid A Mark
Pageof 205

Showing results (111-120 of 2,047) with videos related to

Sort By:
Pageof 205
Clinical Advances in Hematology & Oncology : H&O|April 9, 2016
The impact of value-based insurance design on oncology drugsA Mark Fendrick
Circulation. Heart Failure|March 15, 2017
Circulating Biomarkers of Cardiac Fibrosis: Do We Have Any and What Use Are They?A Mark Richards
Journal of Sports Sciences|March 18, 2017
Journal of Sports Sciences: past, present and futureA Mark Williams
The American Journal of Managed Care|November 25, 2003
Mechanisms to improve pharmaceutical use in managed care: to study controls, control the studiesA Mark Fendrick
Journal of Child Health Care : for Professionals Working with Children in the Hospital and Community|April 20, 2004
ADHD and drug therapy: is it still a valid treatment?A Mark Doggett
Age and Ageing|November 4, 2005
Reversible dementia--the implications of a fall in prevalenceA Mark Clarfield
Canadian Family Physician Medecin De Famille Canadien|September 17, 2002
Treating family members: call your doctor in the morningA Mark Clarfield
The American Journal of Managed Care|December 3, 2002
Cost-effective use of NSAIDs: issues pertinent to coxib use in managed careA Mark Fendrick
Cleveland Clinic Journal of Medicine|June 28, 2002
Developing an economic rationale for the use of selective COX-2 inhibitors for patients at risk for NSAID gastropathyA Mark Fendrick
Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie|January 7, 2003
Protection from aspiration with the LMA-ProSeal after vomiting: a case reportDavid A Mark
Pageof 205